Efficacy and Safety of Roflumilast in Korean Patients with COPD. - Wikidata - awgldk - TriplyDB

Efficacy and Safety of Roflumilast in Korean Patients with COPD.

Efficacy and Safety of Roflumilast in Korean Patients with COPD.

http://www.wikidata.org/entity/Q37110198

about

Phosphodiesterase 4 inhibitors for chronic obstructive pulmonary disease.Effect and safety of roflumilast for chronic obstructive pulmonary disease in Chinese patients.

P2860

Q47551310-8C7FE3A2-11B0-47FD-B1C7-EEB3B43CAD00 Q50003346-BCDD2A84-A717-4956-B08A-F43792D2C5DE

P2860

Efficacy and Safety of Roflumilast in Korean Patients with COPD.

http://www.wikidata.org/entity/Q37110198

description

article científic

@ca

article scientifique

@fr

articolo scientifico

@it

artigo científico

@pt

bilimsel makale

@tr

scientific article published on July 2016

@en

vedecký článok

@sk

vetenskaplig artikel

@sv

videnskabelig artikel

@da

vědecký článek

@cs

name

Efficacy and Safety of Roflumilast in Korean Patients with COPD.

@en

Efficacy and Safety of Roflumilast in Korean Patients with COPD.

@nl

type

label

Efficacy and Safety of Roflumilast in Korean Patients with COPD.

@en

Efficacy and Safety of Roflumilast in Korean Patients with COPD.

@nl

prefLabel

Efficacy and Safety of Roflumilast in Korean Patients with COPD.

@en

Efficacy and Safety of Roflumilast in Korean Patients with COPD.

@nl

P1433

Q37110198-643055FF-87E6-4FB8-AE33-1EFAAFA7EC93

P1476

Q37110198-48E92634-BCAE-4275-B3B0-89DF0EB8ECBE

P2093

Q37110198-262582F9-0ADC-470A-90A3-50678E1FE4B7

Q37110198-4F5E6B93-4DE3-4BE7-A640-DDEC8B00DACD

Q37110198-54638C48-523A-4CA6-A3CF-15A9936111FF

Q37110198-9AC55EB5-5DCD-4767-B0E1-87AF57ED6D79

Q37110198-D86C8329-DD71-489C-AFE3-F3F60F3A837E

Q37110198-F61C06D2-C876-4E52-BA34-17E34B23C7D3

P2860

Q37110198-0A7A78FC-8469-43DC-A076-6FD34F163BF2

Q37110198-1234C235-3680-4BD6-A724-1D352B66B83E

Q37110198-1310B216-759B-48ED-AD1E-7D13FBFFCF5D

Q37110198-14FF7E69-BE26-43F1-8292-F4499E80325A

Q37110198-371F7E49-A2AF-42DA-A87E-BD85CF2AA172

Q37110198-3B3041B4-78A9-4641-8489-446F66BACAA8

Q37110198-423202D1-1A32-432A-8184-B2C3F2B1FDA9

Q37110198-47C2B6F1-81AA-40C0-867E-4A4BE31169AB

Q37110198-53F5B1A7-DA86-4B9A-8EF3-BA367DD6CB35

Q37110198-600AEEDD-C77A-45FD-B90F-7CF90BD39B74

P304

Q37110198-59EFBC21-6CA5-4AD8-8E14-44639877F597

P31

Q37110198-76CC9E62-B52F-4DF5-894C-BF9E1F852EAC

P356

Q37110198-F83A403B-AEB7-4D50-ADF3-119126D423DF

P433

Q37110198-085361B8-AB44-4D9B-924B-43478A55A856

P478

Q37110198-5A19DB1A-C6C3-40D2-A19C-DE62C05A71B7

P577

Q37110198-51357787-6127-42D9-8DEE-04CC5A2A78BD

P698

Q37110198-89F2E343-1455-4A39-B6A9-4E9310ACCB5B

P921

Q37110198-F3FB01FA-0864-4309-B082-E3B3B36F2561

P932

Q37110198-141ADF86-A91D-49B3-B435-0F84FD0CA217

P356

YMJ.2016.57.4.928

P1433

Yonsei Medical Journal

P1476

Efficacy and Safety of Roflumilast in Korean Patients with COPD.

@en

P2093

Jae Seung Lee

http://www.w3.org/2001/XMLSchema#string

Sang Do Lee

http://www.w3.org/2001/XMLSchema#string

Sei Won Lee

http://www.w3.org/2001/XMLSchema#string

Tae Sun Park

http://www.w3.org/2001/XMLSchema#string

Yeon Mok Oh

http://www.w3.org/2001/XMLSchema#string

Yoon Ki Hong

http://www.w3.org/2001/XMLSchema#string

P2860

Projections of global mortality and burden of disease from 2002 to 2030

Salmeterol and fluticasone propionate and survival in chronic obstructive pulmonary disease

Roflumilast in symptomatic chronic obstructive pulmonary disease: two randomised clinical trials.

Comparison of Korean COPD guideline and GOLD initiative report in term of acute exacerbation: a validation study for Korean COPD guideline.

Reduction of exacerbations by the PDE4 inhibitor roflumilast--the importance of defining different subsets of patients with COPD.

Predictors of pulmonary function response to treatment with salmeterol/fluticasone in patients with chronic obstructive pulmonary disease

A randomized, controlled trial of theophylline in patients with severe chronic obstructive pulmonary disease.

Inhaled corticosteroids in patients with stable chronic obstructive pulmonary disease: a systematic review and meta-analysis.

Oral theophylline for chronic obstructive pulmonary disease.

Comparison of clinico-physiologic and CT imaging risk factors for COPD exacerbation

P304

928-935

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.3349/YMJ.2016.57.4.928

http://www.w3.org/2001/XMLSchema#string

P433

4

http://www.w3.org/2001/XMLSchema#string

P478

57

http://www.w3.org/2001/XMLSchema#string

P577

2016-07-01T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P698

27189287

http://www.w3.org/2001/XMLSchema#string

P921

chronic obstructive pulmonary disease

P932

4951470

http://www.w3.org/2001/XMLSchema#string